MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
for Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
38 locations incl. Tucson
Sponsor: Intellia Therapeutics
Sex: All·Age: 18 - 90
Code: NCT06128629·Phase 3·Recruiting